Chinese pharmaceutical innovation is reshaping global healthcare, overtaking the US in research volume and pioneering new medical treatments.
You must be a subscriber to access all of this content.
Biovac secures major funding for African vaccine manufacturing. The expansion is supported with funds from the EIB and IFC.
You must be a subscriber to access all of this content.
SA’s NHI Design can benefit from China’s healthcare model which includes structured plurality, private schemes, and fiscal discipline.
You must be a subscriber to access all of this content.
Daraxonrasib pancreatic cancer trial results show that Revolution Medicines' new therapy is doubling survival rates and reshaping oncology.
You must be a subscriber to access all of this content.
A recent study highlights the generative AI health information risks in chatbots, emphasising the dangers of inaccurate advice.
You must be a subscriber to access all of this content.